Mounjaro Diabetes

Your guide to
MOUNJARO^® (tirzepatide) and the KwikPen^® device

TYPE 2 DIABETES

Your healthcare professional may prescribe Mounjaro:

On its own when you can’t take metformin (another diabetes medicine)
With other medicines for diabetes when they are not enough to control your blood sugar levels. These other medicines may be medicines taken by mouth and/or insulin given by injection

Do not use Mounjaro:

If you are allergic to Mounjaro or any of the other ingredients of this medicine (listed in section 6 of your Patient Information Leaflet (PIL))

This website is produced by Eli Lilly and Company, the manufacturer of this medicine.

This information does not replace the PIL or the Instructions for Use (IFU) that accompanies your medicine. Please read the PIL and IFU carefully

Watch a video on how to use the MOUNJARO KWIKPEN

This medicine is subject to additional monitoring.
This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See www.mhra.gov.uk/yellowcard for how to report side effects. Click here for the information on how to report side effects at the bottom of the page.

PP-TR-GB-0920 December 2024

Resources

Your guide to MOUNJARO ^® (tirzepatide) and the KwikPen device

Download Patient Brochure

Watch a video on how to use the Mounjaro KwikPen

Instructions for Use

Patient Information Leaflet

Mounjaro 2.5 mg KwikPen – Shelf Life Extension

We wish to inform you that specific batches of Mounjaro 2.5 mg KwikPen have been granted an extension of shelf life from 9 months to 14 months. The letter linked below provides more information if you have been prescribed product from an affected batch.
Download

REPORTING SIDE EFFECTS

SIDE EFFECTS AND PRODUCT COMPLAINTS SHOULD BE REPORTED

If you experience side effects talk to your doctor or other healthcare professional. This includes any possible side effects not listed in the package leaflet. To report a side effect or product complaint with a Lilly product please call Lilly on 01256 315 000. Additionally reporting forms and further information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects you can help provide more information on the safety of medicines.

Mounjaro ^®, KwikPen ^® and Lilly are registered trademarks of Eli Lilly and Company.
This website is published by Eli Lilly and Company, the manufacturer of this medicine, and is intended for people prescribed Mounjaro in Great Britain.

Reporting Side Effects

You are now leaving diabetes.mounjaro.co.uk

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Eli Lilly and Company and its affiliates do not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Eli Lilly and Company and its affiliates. Eli Lilly and Company and its affiliates are not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.